<?xml version="1.0" encoding="UTF-8"?>
<p>Thus, the four ligands are from Asinex databases and their binding free energies (Δ
 <italic>G</italic> bind) on each sites (Site 1, Site 2, Site 3) are 5817 (−38.79, −47.93, −45.23); 6799 (−44.61, −29.47, −46.49); 6797(−40.21, −35.18, −46.54) and 7025 (−33.96, −51.99, −61.45). However, three drugs accomplished from PubChem databases and their binding free energies (Δ
 <italic>G</italic> bind) on each sites (Site 1, Site 2, Site 3) are Zidovudine (−23.50, −16.37, −44.64), Valganciclovir (−49.88, −39.44, −48.05) and Ribavirin (−40.92, −47.82, −44.96) (
 <xref rid="t0006" ref-type="table">Table 6</xref>). Further ranking of these molecules is done by rescoring MM-GBSA functions. It indicates change in free energies of binding of protein–receptor complex and corroborates binding affinities and docking accuracies. The number of HBs interaction, docking score and binding free energies with that site (
 <xref rid="t0003 t0004 t0005" ref-type="table">Tables 3–5</xref>) depict the binding capacity of a ligand to the target.
</p>
